Wall Street analysts changed outlook on top names. Check analyst ratings page for all changes. See w

Morgan Stanley analyst Maxwell Skor initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) wit

Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.80) per share which missed the

Closed a private placement of up to $354 million, with $180 million upfront and up to $174 million f

SEATTLE and VANCOUVER, British Columbia, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, In

SEATTLE and VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, In

Achieve Life Sciences, Inc. (NASDAQ: ACHV - Get Free Report) was up 6.5% during mid-day trading on F

US stock futures mostly higher, Nasdaq up by 100 points. Phoenix Education falls after cutting sales

Achieve Life Sciences NASDAQ: ACHV held its 2026 Annual Meeting of Stockholders virtually, with Chie

The last months were eventful for Achieve Life Sciences, sending the stock strongly down, but later

Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmace

SEATTLE and VANCOUVER, British Columbia, June 29, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, In

Achieve Life Sciences remains a cytisinicline story, with very positive smoking-cessation data. This

Achieve Life Sciences Inc. (NASDAQ:ACHV) on Monday received a Complete Response Letter (CRL) from th

FDA rejects Achieve Life Sciences application for cytisinicline tied to manufacturing issues, with N

HC Wainwright & Co. analyst Brandon Folkes reiterates Achieve Life Sciences (NASDAQ:ACHV) wit

The U.S. Food and Drug Administration ​has declined to approve Achieve Life ‌Sciences' drug to treat

Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmace

CRL Cites Deficiencies at Third-Party Manufacturing Facility No Efficacy or Clinical Safety Deficien

Retail investors talked up five hot stocks this week (June 15 to June 18) on X and Reddit's r/Wa

Appointments Add Deep Biopharmaceutical Commercial Strategy, Clinical and Finance Expertise as Compa

ORCA-OL data complete the clinical evidence package supporting the cytisinicline smoking cessation N

Achieve Life Sciences (ACHV) is downgraded to 'Hold' due to anticipated CRL of cytisinicline for smo

Achieve Life Sciences, Inc. (ACHV) Q1 2026 Earnings Call Transcript

Achieve Life Sciences NASDAQ: ACHV used its first-quarter 2026 earnings call to outline a transition

Christopher Martin joins the Board of Directors, with Mark Zappia and Jim Willis joining as Senior V

Closed Private Placement of Up to $354 Million, Including $180 Million Upfront and $174 Million in M

SEATTLE and VANCOUVER, British Columbia, May 05, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc

Canaccord Genuity analyst Gary Nachman initiates coverage on Achieve Life Sciences (NASDAQ:ACHV)

Achieve Names Two New Exemplary Healthcare Leaders to its Board of Directors New Leadership and Fina

HC Wainwright & Co. analyst Brandon Folkes reiterates Achieve Life Sciences (NASDAQ:ACHV) wit

Adare Partnership Provides Supply Chain Redundancy and U.S.-based Manufacturing CapabilityCompany Re

Achieve Life Sciences taps Adare for cytisinicline manufacturing as stock falls; reports wider losse

HC Wainwright & Co. analyst Brandon Folkes reiterates Achieve Life Sciences (NASDAQ:ACHV) wit

Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.28) per share which missed the

Achieve also announces late-breaking survey data from ORCA-OL, demonstrating participant experience

From time to time, we may offer up to $300,000,000 aggregate amount of shares of our common stock or

Biotech stocks have trailed the broader market this year, but more names are starting to show streng

The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for can